Association Between EEG Patterns and Serum Neurofilament Light After Cardiac Arrest: A Post Hoc Analysis of the TTM Trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 687 KB, PDF-dokument

  • Linnéa Grindegård
  • Tobias Cronberg
  • Sofia Backman
  • Kaj Blennow
  • Josef Dankiewicz
  • Hans Friberg
  • Hassager, Christian
  • Janneke Horn
  • Troels W. Kjaer
  • Kjærgaard, Jesper
  • Michael Kuiper
  • Niklas Mattsson-Carlgren
  • Niklas Nielsen
  • Anne Fleur Van Rootselaar
  • Andrea O. Rossetti
  • Pascal Stammet
  • Susann Ullén
  • Henrik Zetterberg
  • Erik Westhall
  • Marion Moseby-Knappe

Background and ObjectivesEEG is widely used for prediction of neurologic outcome after cardiac arrest. To better understand the relationship between EEG and neuronal injury, we explored the association between EEG and neurofilament light (NfL) as a marker of neuroaxonal injury, evaluated whether highly malignant EEG patterns are reflected by high NfL levels, and explored the association of EEG backgrounds and EEG discharges with NfL.MethodsWe performed a post hoc analysis of the Target Temperature Management After Out-of-Hospital Cardiac Arrest trial. Routine EEGs were prospectively performed after the temperature intervention ≥36 hours postarrest. Patients who awoke or died prior to 36 hours postarrest were excluded. EEG experts blinded to clinical information classified EEG background, amount of discharges, and highly malignant EEG patterns according to the standardized American Clinical Neurophysiology Society terminology. Prospectively collected serum samples were analyzed for NfL after trial completion. The highest available concentration at 48 or 72 hours postarrest was used.ResultsA total of 262/939 patients with EEG and NfL data were included. Patients with highly malignant EEG patterns had 2.9 times higher NfL levels than patients with malignant patterns and NfL levels were 13 times higher in patients with malignant patterns than those with benign patterns (95% CI 1.4-6.1 and 6.5-26.2, respectively; effect size 0.47; p < 0.001). Both background and the amount of discharges were independently strongly associated with NfL levels (p < 0.001). The EEG background had a stronger association with NfL levels than EEG discharges (R2 = 0.30 and R2 = 0.10, respectively). NfL levels in patients with a continuous background were lower than for any other background (95% CI for discontinuous, burst-suppression, and suppression, respectively: 2.26-18.06, 3.91-41.71, and 5.74-41.74; effect size 0.30; p < 0.001 for all). NfL levels did not differ between suppression and burst suppression. Superimposed discharges were only associated with higher NfL levels if the EEG background was continuous.DiscussionBenign, malignant, and highly malignant EEG patterns reflect the extent of brain injury as measured by NfL in serum. The extent of brain injury is more strongly related to the EEG background than superimposed discharges. Combining EEG and NfL may be useful to better identify patients misclassified by single methods.

OriginalsprogEngelsk
TidsskriftNeurology
Vol/bind98
Udgave nummer24
Sider (fra-til)E2487-E2498
ISSN0028-3878
DOI
StatusUdgivet - 2022

Bibliografisk note

Funding Information:
The Article Processing Charge was funded by the authors.

Funding Information:
Funding for the study was provided by the Swedish Research Council; Swedish Heart Lung Foundation; Arbetsmarknadens Försäkringsaktiebolag Insurance Foundation; the Skåne University Hospital Foundations; the Gyllenstierna-Krapperup Foundation; governmental funding of clinical research within the Swedish National Health System, the County Council of Skåne; the Swedish Society of Medicine; the Koch Foundation; TrygFonden (Denmark); European Clinical Research Infrastructures Network; Thelma Zoega Foundation; Stig and Ragna Gorthon Foundation; Thure Carlsson Foundation; Hans-Gabriel and Alice Trolle-Wachtmeister Foundation for Medical Research; Lions Research fund Skåne; South Swedish Hospital Region Research Funds; the Swedish Brain Foundation; the Lundbeck Foundation; and the Torsten Söderberg foundation at the Royal Swedish Academy of Sciences. H.Z. is a Wallenberg Scholar. N.M.-C. is a Wallenberg Molecular Medicine Fellow. The funding organizations had no role in the design and conduct of the study or in the decision to submit the manuscript for publication.

Publisher Copyright:
© 2022 American Academy of Neurology.

ID: 330473116